A 27-year-old G3P2002 presents to the clinic for follow up after her initial prenatal visit. Her last period was 8 weeks ago. Her medical history is notable for obesity, hypertension, type 2 diabetes, and eczema. Her current two children are healthy. Her current pregnancy is with a new partner after she separated from her previous partner. Her vaccinations are up to date since the delivery of her second child. Her temperature is 98°F (37°C), blood pressure is 110/60 mmHg, pulse is 85/min, and respirations are 18/min. Her physical exam is unremarkable. Laboratory results are shown below:
Hemoglobin: 14 g/dL
Hematocrit: 41%
Leukocyte count: 9,000/mm^3 with normal differential
Platelet count: 210,000/mm^3
Blood type: O
Rh status: Negative
Urine:
Epithelial cells: Rare
Glucose: Positive
WBC: 5/hpf
Bacterial: None
Rapid plasma reagin: Negative
Rubella titer: > 1:8
HIV-1/HIV-2 antibody screen: Negative
Gonorrhea and Chlamydia NAAT: negative
Pap smear: High-grade squamous intraepithelial lesion (HGSIL)
What is the best next step in management?
Q2
A 38-year-old G2P2 presents to her gynecologist to discuss the results of her diagnostic tests. She has no current complaints or concurrent diseases. She underwent a tubal ligation after her last pregnancy. Her last Pap smear showed a high-grade squamous intraepithelial lesion and a reflex HPV test was positive. Colposcopic examination reveals areas of thin acetowhite epithelium with diffuse borders and fine punctation. The biopsy obtained from the suspicious areas shows CIN 1. Note the discordancy between the cytology (HSIL) and histology (CIN 1) results. Which of the following is an appropriate next step in the management of this patient?
Q3
A 27-year-old female presents to her OB/GYN for a check-up. During her visit, a pelvic exam and Pap smear are performed. The patient does not have any past medical issues and has had routine gynecologic care with normal pap smears every 3 years since age 21. The results of the Pap smear demonstrate atypical squamous cells of undetermined significance (ASCUS). Which of the following is the next best step in the management of this patient?
Q4
A 27-year-old woman comes to the physician for a routine health maintenance examination. She feels well. She had a chlamydia infection at the age of 22 years that was treated. Her only medication is an oral contraceptive. She has smoked one pack of cigarettes daily for 6 years. She has recently been sexually active with 3 male partners and uses condoms inconsistently. Her last Pap test was 4 years ago and results were normal. Physical examination shows no abnormalities. A Pap test shows atypical squamous cells of undetermined significance. Which of the following is the most appropriate next step in management?
Q5
A 67-year-old woman with endometrial cancer undergoes robotic-assisted staging surgery. Final pathology reveals grade 2 endometrioid adenocarcinoma with 60% myometrial invasion, positive pelvic lymph nodes (2/15), negative para-aortic nodes (0/8), and lymphovascular space invasion. No cervical or adnexal involvement. The tumor care team debates adjuvant treatment. Evaluate which combination of pathologic features most significantly impacts treatment recommendations?
Q6
A 29-year-old woman with stage IA1 cervical cancer (3 mm invasion, no LVSI) desires fertility preservation. She has one child and wants more children. Cone biopsy margins are positive. Imaging shows no lymph node involvement. Her oncologist recommends radical hysterectomy, while a fertility specialist suggests radical trachelectomy. The patient strongly desires future pregnancy. Evaluate the optimal management strategy balancing oncologic and reproductive outcomes.
Q7
A 42-year-old woman with BMI 42 kg/m² and abnormal uterine bleeding undergoes robotic-assisted total laparoscopic hysterectomy. Intraoperatively, she requires steep Trendelenburg positioning for 180 minutes. Postoperatively, she develops dyspnea, hypoxemia, and facial edema. Chest X-ray shows pulmonary edema. Evaluation of her postoperative course requires synthesis of which pathophysiologic mechanisms?
Q8
A 35-year-old woman with BRCA1 mutation presents for risk-reducing bilateral salpingo-oophorectomy. She has completed childbearing and wants to minimize cancer risk. Preoperatively, her CA-125 is normal and transvaginal ultrasound shows normal ovaries. During surgery, the right ovary appears irregular with a 2 cm solid area. Frozen section shows borderline serous tumor. Analysis of treatment options must consider which factor most significantly?
Q9
A 48-year-old woman with uterine prolapse undergoes vaginal hysterectomy with anterior and posterior colporrhaphy. During the procedure, while developing the bladder flap, the surgeon notices immediate filling of the surgical field with clear fluid. A 1 cm bladder injury is identified at the dome. Analysis of this complication reveals it occurred due to which anatomical relationship?
Q10
A 62-year-old woman undergoes staging laparotomy for ovarian cancer. Intraoperatively, she is found to have stage IIIC disease with diffuse peritoneal involvement, omental caking, and multiple liver surface nodules. After optimal cytoreduction, 5 mm residual disease remains on the diaphragm. Frozen section confirms high-grade serous carcinoma. Analysis of the surgical outcome reveals which prognostic factor most impacts survival?
cone biopsy) US Medical PG Practice Questions and MCQs
Question 1: A 27-year-old G3P2002 presents to the clinic for follow up after her initial prenatal visit. Her last period was 8 weeks ago. Her medical history is notable for obesity, hypertension, type 2 diabetes, and eczema. Her current two children are healthy. Her current pregnancy is with a new partner after she separated from her previous partner. Her vaccinations are up to date since the delivery of her second child. Her temperature is 98°F (37°C), blood pressure is 110/60 mmHg, pulse is 85/min, and respirations are 18/min. Her physical exam is unremarkable. Laboratory results are shown below:
Hemoglobin: 14 g/dL
Hematocrit: 41%
Leukocyte count: 9,000/mm^3 with normal differential
Platelet count: 210,000/mm^3
Blood type: O
Rh status: Negative
Urine:
Epithelial cells: Rare
Glucose: Positive
WBC: 5/hpf
Bacterial: None
Rapid plasma reagin: Negative
Rubella titer: > 1:8
HIV-1/HIV-2 antibody screen: Negative
Gonorrhea and Chlamydia NAAT: negative
Pap smear: High-grade squamous intraepithelial lesion (HGSIL)
What is the best next step in management?
A. Repeat Pap smear
B. Colposcopy and biopsy now (Correct Answer)
C. Colposcopy and biopsy after delivery
D. Loop electrosurgical excision procedure (LEEP)
E. Cryosurgical excision
Explanation: **Colposcopy and biopsy now**
- A finding of **high-grade squamous intraepithelial lesion (HGSIL)** during pregnancy warrants immediate **colposcopy** to evaluate the extent of the cervical abnormality.
- **Biopsy** should be performed if indicated during colposcopy to rule out **invasive cancer**, as delaying diagnosis could worsen prognosis.
*Repeat Pap smear*
- Repeating the Pap smear is not appropriate because a **HGSIL** result indicates a significant abnormality requiring further diagnostic evaluation, not just re-screening.
- Delaying definitive diagnosis could lead to progression of a high-grade lesion or missing an **invasive cancer**.
*Colposcopy and biopsy after delivery*
- While some procedures can be deferred, delaying colposcopy and biopsy for a **HGSIL** until after delivery is not recommended due to the risk of **progression to invasive cancer** during pregnancy.
- Close monitoring with colposcopy and biopsy for suspected high-grade lesions or cancer is **safe** during pregnancy.
*Loop electrosurgical excision procedure (LEEP)*
- **LEEP** is an excisional procedure that removes cervical tissue and is typically used for diagnosed **cervical intraepithelial neoplasia (CIN) 2/3 or AIS**, not as the initial diagnostic step for HGSIL during pregnancy.
- It carries a risk of obstetric complications, such as **preterm delivery**, and is generally deferred until after pregnancy unless invasive cancer is suspected.
*Cryosurgical excision*
- **Cryosurgery** is an ablative treatment used for low-grade cervical lesions (CIN 1) or in some cases of CIN 2, but it is not indicated for **HGSIL** as an initial step, especially during pregnancy where tissue diagnosis is crucial.
- It is an ablative treatment that destroys tissue without obtaining a specimen for histopathological evaluation, which is necessary to rule out **invasive malignancy**.
Question 2: A 38-year-old G2P2 presents to her gynecologist to discuss the results of her diagnostic tests. She has no current complaints or concurrent diseases. She underwent a tubal ligation after her last pregnancy. Her last Pap smear showed a high-grade squamous intraepithelial lesion and a reflex HPV test was positive. Colposcopic examination reveals areas of thin acetowhite epithelium with diffuse borders and fine punctation. The biopsy obtained from the suspicious areas shows CIN 1. Note the discordancy between the cytology (HSIL) and histology (CIN 1) results. Which of the following is an appropriate next step in the management of this patient?
A. Test for type 16 and 18 HPV
B. Cryoablation
C. Cold-knife conization
D. Loop electrosurgical excision procedure
E. Repeat cytology and HPV co-testing in 6 months (Correct Answer)
Explanation: ***Repeat cytology and HPV co-testing in 6 months***
- In cases of **discordant results** where cytology shows **HSIL** but histology only shows **CIN 1**, repeat co-testing in 6 months is an appropriate management strategy, especially if the **colposcopy was satisfactory** (entire squamocolumnar junction visualized). This approach allows for monitoring while avoiding overtreatment, as many low-grade lesions spontaneously regress.
- Given the patient's history (G2P2, tubal ligation), future fertility is not a concern, making conservative management suitable when there's uncertainty about the severity of the lesion.
*Test for type 16 and 18 HPV*
- The patient already has a **positive reflex HPV test**, indicating the presence of high-risk HPV. Knowing the specific types (16 or 18) would assist in risk stratification, but it would not change the immediate management given the existing discordance between HSIL cytology and CIN 1 histology.
- While **HPV 16 and 18** are associated with a higher risk of progression to cancer, current guidelines for discordant HSIL/CIN 1 emphasize observation or excisional procedures based on other factors, not just specific HPV typing if HPV is already confirmed as positive.
*Cryoablation*
- **Cryoablation** is an ablative treatment that destroys abnormal cervical tissue. It is typically reserved for confirmed **CIN 2 or CIN 3** with a satisfactory colposcopy, when there is no suspicion of invasive cancer.
- Applying an ablative treatment like cryoablation based on discordant results (HSIL with CIN 1) without further clarification could lead to overtreatment, and it may not fully address the possibility of a missed higher-grade lesion elsewhere.
*Cold-knife conization*
- **Cold-knife conization** is an excisional procedure used to remove a cone-shaped piece of cervical tissue, typically for confirmed **CIN 2 or CIN 3**, or when **colposcopy is unsatisfactory**, or there's a suspicion of invasive disease, or glandular lesions.
- Performing a conization based on HSIL cytology but only CIN 1 histology, without further investigation or follow-up, is premature and unnecessarily aggressive given the potential for an overestimation of disease severity by cytology alone.
*Loop electrosurgical excision procedure*
- **LEEP** is an excisional procedure commonly used for the management of **high-grade cervical intraepithelial neoplasia (CIN 2 or CIN 3)** or when there is a significant discrepancy between cytology and histology that suggests a higher-grade lesion.
- While LEEP is an excisional procedure, it is typically performed when there is a confirmed CIN 2/3, not when histology shows CIN 1, especially given the potential for spontaneous regression and the less invasive options for managing discordant results.
Question 3: A 27-year-old female presents to her OB/GYN for a check-up. During her visit, a pelvic exam and Pap smear are performed. The patient does not have any past medical issues and has had routine gynecologic care with normal pap smears every 3 years since age 21. The results of the Pap smear demonstrate atypical squamous cells of undetermined significance (ASCUS). Which of the following is the next best step in the management of this patient?
A. Repeat Pap smear in 1 year
B. Perform colposcopy
C. Perform an HPV DNA test (Correct Answer)
D. Perform a Loop Electrosurgical Excision Procedure (LEEP)
E. Repeat Pap smear in 3 years
Explanation: ***Perform an HPV DNA test***
- For women aged 25-29 with an **ASCUS Pap smear result**, the recommended next step is to perform an **HPV DNA test** to triage the finding.
- If the HPV test is positive, a colposcopy is indicated. If negative, routine screening can resume.
*Repeat Pap smear in 1 year*
- This approach is typically recommended for adolescents (age < 21) with an ASCUS result or for women aged 21-24 if HPV testing is not available.
- For women aged 25-29, **HPV testing** is preferred to determine the need for colposcopy.
*Perform colposcopy*
- **Colposcopy** is indicated if the HPV DNA test is positive following an ASCUS result in women 25-29, or for persistent ASCUS or low-grade squamous intraepithelial lesion (LSIL) results in younger women.
- It is not the immediate next step for ASCUS in this age group without prior HPV status.
*Perform a Loop Electrosurgical Excision Procedure (LEEP)*
- **LEEP** is a treatment for high-grade cervical dysplasia (HSIL) or recurrent/persistent LSIL, not a diagnostic step for initial ASCUS.
- Performing a LEEP based solely on an **ASCUS result** would be overly aggressive and may lead to unnecessary complications.
*Repeat Pap smear in 3 years*
- **Repeating a Pap smear in 3 years** is the recommendation for women with a normal Pap smear and negative HPV test, or for those who had an ASCUS/LSIL result with negative HPV testing and subsequent normal screening.
- It is not appropriate for an initial ASCUS finding in a 27-year-old.
Question 4: A 27-year-old woman comes to the physician for a routine health maintenance examination. She feels well. She had a chlamydia infection at the age of 22 years that was treated. Her only medication is an oral contraceptive. She has smoked one pack of cigarettes daily for 6 years. She has recently been sexually active with 3 male partners and uses condoms inconsistently. Her last Pap test was 4 years ago and results were normal. Physical examination shows no abnormalities. A Pap test shows atypical squamous cells of undetermined significance. Which of the following is the most appropriate next step in management?
A. Repeat cytology in 6 months
B. Perform laser ablation
C. Perform loop electrosurgical excision procedure
D. Perform HPV testing (Correct Answer)
E. Perform cervical biopsy
Explanation: ***Perform HPV testing***
- For women aged 25-29 with **Atypical Squamous Cells of Undetermined Significance (ASC-US)**, **HPV co-testing** is the preferred next step to risk-stratify for high-grade lesions.
- If **HPV is positive**, the patient should proceed to **colposcopy**; if HPV is negative, she can return to routine screening.
*Repeat cytology in 6 months*
- This approach is typically recommended for adolescents (age <21) with ASC-US or for women aged 21-24 where HPV testing is often not performed due to the high rate of transient HPV infections.
- For women aged ≥25 years with ASC-US, **reflex HPV testing** or **HPV co-testing** (if not done with the initial Pap) is generally preferred over repeat cytology alone.
*Perform laser ablation*
- **Laser ablation** is a treatment for **high-grade cervical intraepithelial neoplasia (CIN2/3)** identified after colposcopy and biopsy, not for initial ASC-US findings.
- Initiating a destructive procedure without further diagnostic evaluation would be premature and over-treatment for ASC-US.
*Perform loop electrosurgical excision procedure*
- **LEEP (loop electrosurgical excision procedure)** is a **diagnostic and therapeutic procedure** typically reserved for confirmed **high-grade CIN (CIN2 or CIN3)** or adenocarcinoma in situ.
- It is an invasive procedure and not appropriate as the initial management step for an ASC-US Pap result.
*Perform cervical biopsy*
- A **cervical biopsy** is performed during a **colposcopy** if abnormal areas are identified, usually following a positive HPV test or higher-grade abnormal cytology (e.g., LSIL, HSIL).
- ASC-US alone does not automatically warrant an immediate colposcopy and biopsy without prior **HPV risk stratification**.
Question 5: A 67-year-old woman with endometrial cancer undergoes robotic-assisted staging surgery. Final pathology reveals grade 2 endometrioid adenocarcinoma with 60% myometrial invasion, positive pelvic lymph nodes (2/15), negative para-aortic nodes (0/8), and lymphovascular space invasion. No cervical or adnexal involvement. The tumor care team debates adjuvant treatment. Evaluate which combination of pathologic features most significantly impacts treatment recommendations?
A. Grade 2 histology and depth of myometrial invasion
B. Number of positive nodes and total nodes removed
C. Lymphovascular space invasion and myometrial invasion depth
D. Positive pelvic nodes and negative para-aortic nodes (Correct Answer)
E. Absence of cervical involvement and patient age
Explanation: ***Positive pelvic nodes and negative para-aortic nodes***
- The presence of positive pelvic lymph nodes classifies this as **FIGO Stage IIIC1** disease, which is the primary driver for recommending **systemic chemotherapy**.
- The negative para-aortic nodes help delineate the **radiation field**, focusing treatment on the pelvis rather than extended-field radiation, thus making this combination critical for the management plan.
*Grade 2 histology and depth of myometrial invasion*
- While these factors contribute to the **GOG-99** or **PORTEC** risk criteria for early-stage disease, they are superseded by the presence of **nodal metastasis** (Stage IIIC).
- Myometrial invasion (>50%) and Grade 2 are baseline risk factors, but they do not dictate the switch from local to **systemic therapy** once nodes are positive.
*Number of positive nodes and total nodes removed*
- The **lymph node count** (2/15) confirms the stage but does not change the treatment algorithm as much as the **anatomical location** (pelvic vs. para-aortic) of those nodes.
- While a low total node count might suggest staging inadequacy, Stage IIIC status is already established here, making the **distribution** more clinically significant for therapy planning.
*Lymphovascular space invasion and myometrial invasion depth*
- **Lymphovascular space invasion (LVSI)** is a strong prognostic indicator for recurrence, but it is often a precursor to the nodal involvement already identified in this patient.
- These features are used to justify **adjuvant therapy** in early-stage (Stage I) patients, but nodal status is a more powerful determinant in Stage III disease.
*Absence of cervical involvement and patient age*
- The lack of **cervical stromal invasion** means the patient is not Stage II, but this is less impactful than the upgrade to **Stage IIIC** due to positive nodes.
- **Patient age** is a clinical factor used in risk-stratification models like **GOG-99**, but it does not outweigh the pathological finding of **metastasized disease** in treatment selection.
Question 6: A 29-year-old woman with stage IA1 cervical cancer (3 mm invasion, no LVSI) desires fertility preservation. She has one child and wants more children. Cone biopsy margins are positive. Imaging shows no lymph node involvement. Her oncologist recommends radical hysterectomy, while a fertility specialist suggests radical trachelectomy. The patient strongly desires future pregnancy. Evaluate the optimal management strategy balancing oncologic and reproductive outcomes.
A. Repeat cone biopsy followed by close surveillance (Correct Answer)
B. Radical hysterectomy given positive margins
C. Simple trachelectomy with sentinel lymph node biopsy
D. Radical trachelectomy with pelvic lymphadenectomy
E. Neoadjuvant chemotherapy followed by conservative surgery
Explanation: ***Repeat cone biopsy followed by close surveillance***
- In **Stage IA1** cervical cancer without **lymphovascular space invasion (LVSI)**, achieving **negative margins** via a repeat conization is standard to ensure all microscopic disease is removed while preserving the uterus.
- This approach is the most conservative and effective strategy for **fertility preservation**, as the risk of **lymph node metastasis** is less than 1% in this specific pathological subgroup.
*Radical hysterectomy given positive margins*
- This procedure provides definitive oncologic treatment but results in **permanent infertility**, which violates the patient's strong preference for **fertility preservation**.
- Radical surgery is considered **overtreatment** for Stage IA1 disease without LVSI, provided that negative margins can be achieved through additional local excision.
*Simple trachelectomy with sentinel lymph node biopsy*
- While a trachelectomy preserves fertility, a **simple trachelectomy** would still leave the positive margins from the initial cone biopsy untreated if not mapped correctly.
- **Sentinel lymph node biopsy** is generally not required for Stage IA1 disease lacking LVSI because the risk of nodal involvement is extremely low.
*Radical trachelectomy with pelvic lymphadenectomy*
- This is an extensive procedure typically reserved for **Stage IA2 to IB1** disease or Stage IA1 with **positive LVSI**, making it too aggressive for this patient's diagnosis.
- It carries higher risks of surgical morbidity and **obstetric complications**, such as preterm labor and cervical insufficiency, compared to a repeat cone biopsy.
*Neoadjuvant chemotherapy followed by conservative surgery*
- **Neoadjuvant chemotherapy (NACT)** is not an indicated or standard treatment for early-stage (IA1) cervical cancer with minimal stromal invasion.
- NACT is typically explored in research settings for **bulky Stage IB** tumors to shrink them prior to performing **fertility-sparing surgery**, which does not apply here.
Question 7: A 42-year-old woman with BMI 42 kg/m² and abnormal uterine bleeding undergoes robotic-assisted total laparoscopic hysterectomy. Intraoperatively, she requires steep Trendelenburg positioning for 180 minutes. Postoperatively, she develops dyspnea, hypoxemia, and facial edema. Chest X-ray shows pulmonary edema. Evaluation of her postoperative course requires synthesis of which pathophysiologic mechanisms?
A. Prolonged Trendelenburg causing increased intrathoracic pressure and facial venous congestion
B. Combination of increased preload from positioning, obesity-related cardiac strain, and capillary leak (Correct Answer)
C. Obesity hypoventilation syndrome exacerbated by anesthesia residual effects
D. CO2 absorption from pneumoperitoneum causing hypercarbia and pulmonary vasoconstriction
E. Undiagnosed obstructive sleep apnea causing negative pressure pulmonary edema
Explanation: ***Combination of increased preload from positioning, obesity-related cardiac strain, and capillary leak***
- Steep **Trendelenburg positioning** causes a significant shift of blood volume toward the heart, leading to increased **central venous pressure** and cardiac **preload**, which can overwhelm the left ventricle.
- In patients with a high **BMI**, the heart already handles increased workload; the addition of prolonged surgery and **fluid resuscitation** promotes **capillary leak** and hydrostatic fluid movement into the pulmonary alveoli.
*Prolonged Trendelenburg causing increased intrathoracic pressure and facial venous congestion*
- While this positioning does cause **venous congestion** and increases **intrathoracic pressure**, it does not fully explain the development of **pulmonary edema** on chest X-ray.
- This mechanism explains the **facial edema** and potential airway swelling but fails to address the underlying **cardiac and systemic fluid shifts** described.
*Obesity hypoventilation syndrome exacerbated by anesthesia residual effects*
- **Obesity hypoventilation syndrome** leads to hypercapnia and chronic hypoxemia, but it typically presents with **respiratory acidosis** rather than acute pulmonary edema.
- While anesthesia can suppress respiratory drive, it would not primarily cause the **interstitial fluid accumulation** seen in this patient's imaging.
*CO2 absorption from pneumoperitoneum causing hypercarbia and pulmonary vasoconstriction*
- **Pneumoperitoneum** does lead to **CO2 absorption** and systemic absorption, but modern anesthesia management typically compensates for this through ventilation adjustments.
- While **pulmonary vasoconstriction** can occur, it is a transient physiological change and is rarely the solitary cause of post-operative **pulmonary edema** in this clinical context.
*Undiagnosed obstructive sleep apnea causing negative pressure pulmonary edema*
- **Negative pressure pulmonary edema** occurs due to strong inspiratory effort against an **obstructed airway** (laryngospasm), typically during extubation.
- This patient's symptoms developed over a **180-minute procedure** and involve facial edema, suggesting fluid overload and positioning rather than an acute **post-extubation crisis**.
Question 8: A 35-year-old woman with BRCA1 mutation presents for risk-reducing bilateral salpingo-oophorectomy. She has completed childbearing and wants to minimize cancer risk. Preoperatively, her CA-125 is normal and transvaginal ultrasound shows normal ovaries. During surgery, the right ovary appears irregular with a 2 cm solid area. Frozen section shows borderline serous tumor. Analysis of treatment options must consider which factor most significantly?
A. The patient's BRCA1 mutation status increasing malignant transformation risk
B. Risk of occult invasive cancer in the contralateral ovary
C. Need for complete staging with lymphadenectomy
D. Frozen section accuracy limitations for borderline tumors (Correct Answer)
E. Patient's prior consent for risk-reducing surgery
Explanation: ***Frozen section accuracy limitations for borderline tumors***
- **Frozen section** of borderline ovarian tumors has a high rate of discordance (up to 30%) with the **final permanent pathology**, often underestimating the degree of invasion.
- Because a **borderline tumor** could potentially be upgraded to an **invasive carcinoma** on permanent section, this limitation is the most critical factor when deciding if more extensive staging is required immediately.
*The patient's BRCA1 mutation status increasing malignant transformation risk*
- While **BRCA1 mutations** significantly increase the risk for **invasive serous ovarian cancer**, they are not specifically associated with a higher risk for **borderline serous tumors** themselves.
- The management of the current surgical finding depends more on the immediate pathologic diagnosis than the background genetic risk profile.
*Risk of occult invasive cancer in the contralateral ovary*
- Although contralateral involvement occurs, the primary management challenge is the accurate identification of the **ipsilateral tumor** histology rather than managing the **contralateral ovary**, which was already intended for removal.
- **Risk-reducing bilateral salpingo-oophorectomy (RRBSO)** already plans for the removal of both ovaries regardless of the frozen section result.
*Need for complete staging with lymphadenectomy*
- **Complete surgical staging** (including lymphadenectomy) is standard for invasive cancer, but its routine use in **borderline tumors** is controversial as it does not typically improve survival.
- The decision to perform staging depends on the reliability of the **frozen section** to exclude invasive disease, which is the underlying management dilemma.
*Patient's prior consent for risk-reducing surgery*
- Consent covers the removal of normal-appearing organs but may not encompass the expanded **oncologic staging** required if a malignancy is confirmed.
- While consent is legally necessary, it does not dictate the **clinical judgment** needed to address an unexpected intraoperative finding of a solid ovarian mass.
Question 9: A 48-year-old woman with uterine prolapse undergoes vaginal hysterectomy with anterior and posterior colporrhaphy. During the procedure, while developing the bladder flap, the surgeon notices immediate filling of the surgical field with clear fluid. A 1 cm bladder injury is identified at the dome. Analysis of this complication reveals it occurred due to which anatomical relationship?
A. Bladder adherent to anterior uterine wall from previous cesarean section (Correct Answer)
B. Abnormal course of ureter crossing the cervix laterally
C. Bladder distension causing cephalad extension
D. Normal vesicouterine peritoneal reflection being too low
E. Weakened pubocervical fascia allowing bladder descent
Explanation: ***Bladder adherent to anterior uterine wall from previous cesarean section***
- A prior **cesarean section** creates fibrous adhesions that obliterate the normal **vesicouterine space**, causing the bladder to be pulled cephalad and fixed to the uterus.
- When the surgeon attempts to develop the **bladder flap**, the lack of a clear tissue plane leads to accidental entry into the **bladder dome** or posterior wall.
*Abnormal course of ureter crossing the cervix laterally*
- While the **ureter** is at risk during hysterectomy, it typically crosses approximately 1.5 cm lateral to the **cervix** under the **uterine artery**.
- Ureteral injury usually results in anuria, flank pain, or a fistula, but it would not cause the immediate drainage of clear fluid from the **vesicouterine space**.
*Bladder distension causing cephalad extension*
- Although a distended bladder can increase the risk of injury by occupying more space in the operative field, surgical protocols require **pre-operative catheterization**.
- Simple distension does not obliterate the **surgical planes** as significantly as pathological adhesions do in the context of previous surgery.
*Normal vesicouterine peritoneal reflection being too low*
- A **low peritoneal reflection** would theoretically make the bladder easier to identify and push away from the cervix, rather than increasing the risk of sharp injury.
- Injury at the **dome** specifically implies that the bladder was not in its expected anatomical position and was likely fixed higher onto the uterine corpus.
*Weakened pubocervical fascia allowing bladder descent*
- Weakness of the **pubocervical fascia** is the primary cause of a **cystocele** (bladder descent), which is often the indication for the anterior colporrhaphy itself.
- Descent of the bladder actually pulls it away from the **uterine dome**, making injury during the fundal dissection of a hysterectomy less likely compared to adhesive disease.
Question 10: A 62-year-old woman undergoes staging laparotomy for ovarian cancer. Intraoperatively, she is found to have stage IIIC disease with diffuse peritoneal involvement, omental caking, and multiple liver surface nodules. After optimal cytoreduction, 5 mm residual disease remains on the diaphragm. Frozen section confirms high-grade serous carcinoma. Analysis of the surgical outcome reveals which prognostic factor most impacts survival?
A. The stage IIIC classification
B. Presence of liver surface involvement
C. The high-grade histology
D. Achievement of residual disease ≤1 cm (Correct Answer)
E. Performance of lymphadenectomy
Explanation: ***Achievement of residual disease ≤1 cm***
- In advanced **epithelial ovarian cancer**, the amount of **residual disease** remaining after primary **cytoreductive surgery** is the most significant independent prognostic factor for survival within the surgeon's control.
- **Optimal cytoreduction** is defined as residual nodules measuring **<1 cm** in maximum diameter, which correlates with significantly improved progression-free and overall survival rates.
*The stage IIIC classification*
- While **FIGO staging** provides essential baseline prognostic information, the patient's survival is more heavily influenced by whether they undergo **optimal debulking** than by the initial extent of the tumor.
- Patients with **Stage IIIC** disease who are optimally debulked often have better outcomes than patients with **Stage II** disease who have large residual tumor loads.
*Presence of liver surface involvement*
- Liver surface nodules (Stage IIIC) are distinct from **parenchymal metastases** (Stage IVB) and do not necessarily preclude a good prognosis if they are successfully removed or reduced during surgery.
- The prognostic weight of **extrapelvic spread** is secondary to the success of the surgical debulking effort and the response to subsequent **platinum-based chemotherapy**.
*The high-grade histology*
- While **high-grade serous carcinoma** is aggressive and typically presents at an advanced stage, it is also highly sensitive to **chemotherapy**, making surgical volume reduction the primary survival driver.
- Histologic grade is a fixed biological variable, whereas the **volume of residual disease** is a modifiable clinical variable that determines the efficacy of adjuvant treatments.
*Performance of lymphadenectomy*
- Routine **lymphadenectomy** in patients with clinically negative nodes and advanced disease (LION trial) has shown no significant survival benefit when **complete macroscopic resection** is achieved.
- The surgical focus in advanced cases remains the total clearance of **peritoneal disease** and omental cakes rather than the extent of retroperitoneal lymph node dissection.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
